SCHEMBL7375223

SCHEMBL7375223

Cc1cc(C)c(S(=O)(=O)[C@@](N)(CN)C(=O)O)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 3/20 0.40
PRSS1 P07477 3/20 0.40
PRSS2 P07478 3/20 0.40
PRSS3 P35030 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
FABP4 P15090 1/20 0.39
RAPGEF4 Q8WZA2 3/20 0.39
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374078 1.00 F2 (0.40) F2PRSS1PRSS2PRSS3CA1
SCHEMBL7375218 1.00 F2 (0.40) F2PRSS1PRSS2PRSS3CA1
SCHEMBL7372959 0.75 ALDH1A1 (0.45) F2PRSS1PRSS2PRSS3CA1
SCHEMBL7376118 0.74 KAT6A (0.43) KMT2A
SCHEMBL8559898 0.73 SLC1A3 (0.40) CA1CA2KMT2A
Hydrochloric Acid SCHEMBL7373016 0.73 KAT6A (0.42) KMT2A
SCHEMBL7451481 0.71 GAA (0.40) MEN1KMT2AL3MBTL1LMNANR3C2
SCHEMBL7651608 0.69 SMN1; SMN2 (0.44) CA1CA2KMT2AMAPTTSHR
SCHEMBL382142 0.69 SMN1; SMN2 (0.44) CA1CA2KMT2AMAPTTSHR
Hydrochloric Acid SCHEMBL382912 0.68 SMN1; SMN2 (0.43) CA1CA2KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP disclosed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO disclosed